最後更新 2024-05-10 07:26:07 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

-1.4%


截至2024-03-31

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

Baxter International Inc.(巴克斯特國際公司)透過其子公司,在全球範圍內開發和提供一系列醫療產品。該公司提供腹膜透析和血液透析,以及其他透析療法和服務;靜脈輸液療法、輸液泵、輸液管組和藥物重構裝置;混合和腫瘤學藥物平台、吸入麻醉和重症護理產品以及藥房調配服務;腸外營養療法及相關產品;用於手術止血、組織封閉和黏著預防的生物產品和醫療器械;以及專注於重症監護室的連續腎臟替代療法和其他器官支持療法。它還提供連接護理解決方案,包括設備、軟件、通信和整合技術;集成患者監測和診斷技術,以幫助診斷、治療和管理各種疾病,包括呼吸療法、心臟病學、視力篩查和身體評估;手術視頻技術、手術桌、燈具、吊臂、精密定位裝置和其他配件。此外,該公司還向各種製藥和生物製藥公司提供合約服務。其產品在醫院、腎臟透析中心、護理院、康復中心、醫生辦公室和在家接受醫生監督的患者中使用。該公司通過直接銷售團隊以及獨立經銷商、藥品批發商和專業藥房或其他替代場所供應商在大約100個國家銷售其產品。它與Celerity Pharmaceutical, LLC達成協議,開發急性護理通用注射預混和腫瘤溶解分子。Baxter International Inc.成立於1931年,總部位於伊利諾伊州迪爾菲爾德。

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

所屬產業

所屬類股
Healthcare
所屬產業
Medical - Instruments & Supplies

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning